LifeArc co-leads £6 million funding in DJS Antibodies
LifeArc announces Seed Fund investment of £2 million in DJS Antibodies, a biotech start-up company pioneering the…
LifeArc announces Seed Fund investment of £2 million in DJS Antibodies, a biotech start-up company pioneering the…
LifeArc to fund two post-doctoral fellowships focused on drug discovery In November 2020, LifeArc initiated a new…
London, UK - KQ Labs, an accelerator programme focused on data-driven health, run by the Francis Crick…
LifeArc has been appointed by the UK Dementia Research Institute (UK DRI) to provide expertise to accelerate…
Funding to help drive the development of new cancer therapies
Mechelen, Belgium, and London, UK, 1 September 2020 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an…
Former Innovate UK Executive Chair joins charity to drive new collaborations and partnerships to benefit patient health.
Clare will be responsible for LifeArc’s investments across the life science sector
KQ Labs is now accepting applications for its third cohort of companies. Early stage data-driven health companies…